Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01057238 · ClinicalTrials.gov registry record · NA
Intensive Communication for Chronically Critically Ill
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 571
- Enrollment target
NCT01057238: Completed NA study, sponsored by Case Western Reserve University.
NCT01057238 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 571 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01057238, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 571 participants
- Enrollment target
Study Summary
This study was a trial of a formal system of family meetings to support family decision makers of chronically critically ill patients in the intensive care unit.
Interventions
- OTHER Intensive Communication System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-05 |
| Phase | NA |
What the finished NCT01057238 record still lists
NCT01057238 is an interventional study that assigns participants to a tested intervention. The registered 571 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which Intensive Communication System is the first listed.
NCT01057238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01057238 about?
NCT01057238 is a clinical study titled "Intensive Communication for Chronically Critically Ill". This study was a trial of a formal system of family meetings to support family decision makers of chronically critically ill patients in the intensive care unit.
What is the current status of trial NCT01057238?
This trial is currently completed. It is a NA study. The enrollment target is 571 participants. The study started on 2005-11. Estimated completion is 2008-05.
What interventions are being tested in trial NCT01057238?
The interventions under investigation include: Intensive Communication System (OTHER).
Who is sponsoring clinical trial NCT01057238?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01057238's enrollment target sits among peer trials
571 180th of 2000 higher than 1,821 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04410796 · 571 participants · Phase 2
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
- NCT06615050 · 572 participants · Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia